Clean Science & Technology Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, showing a decline in both revenue and profitability compared to the previous year. The specialty chemicals manufacturer also declared an interim dividend for shareholders during its board meeting held on January 31, 2026.
Financial Performance Overview
The company's financial performance for Q3FY26 reflected challenging market conditions with significant year-on-year declines across key metrics:
| Metric: |
Q3FY26 |
Q3FY25 |
Change (%) |
| Revenue from Operations: |
₹1,854.90 million |
₹2,315.57 million |
-19.9% |
| Net Profit: |
₹518.97 million |
₹741.09 million |
-30.0% |
| Profit Before Tax: |
₹698.87 million |
₹955.03 million |
-26.8% |
| Basic EPS: |
₹4.88 |
₹6.97 |
-30.0% |
The company's total income for the quarter decreased to ₹1,943.29 million from ₹2,361.53 million in Q3FY25, representing a decline of 17.7%. Other income increased to ₹88.39 million from ₹45.96 million, providing some offset to the operational revenue decline.
EBITDA Performance Analysis
The company's EBITDA performance showed significant pressure during Q3FY26, reflecting the challenging operating environment:
| EBITDA Metrics: |
Q3FY26 |
Q3FY25 |
Change (%) |
| EBITDA: |
₹722 million |
₹984 million |
-26.6% |
| EBITDA Margin: |
33.00% |
40.80% |
-780 bps |
The EBITDA decline of 26.6% to ₹722 million from ₹984 million in Q3FY25 indicates operational challenges beyond just revenue contraction. The EBITDA margin compression to 33% from 40.80% suggests increased cost pressures and reduced operational efficiency during the quarter.
Consolidated Performance Results
On a consolidated basis, Clean Science & Technology reported revenue from operations of ₹2,196.70 million for Q3FY26, compared to ₹2,408.16 million in Q3FY25. The consolidated performance showed similar trends to standalone results:
| Consolidated Metrics: |
Q3FY26 |
Q3FY25 |
Change (%) |
| Revenue from Operations: |
₹2,196.70 million |
₹2,408.16 million |
-8.8% |
| Net Profit: |
₹459.00 million |
₹656.00 million |
-30.0% |
The consolidated net profit of ₹459.00 million represented a 30% decline from ₹656.00 million in the corresponding quarter of the previous year, reflecting the challenging operating environment across the group.
Nine-Month Performance Analysis
For the nine-month period ended December 31, 2025, Clean Science & Technology demonstrated relatively better performance compared to the quarterly results:
| Parameter: |
9M FY26 |
9M FY25 |
Change (%) |
| Revenue from Operations: |
₹6,182.05 million |
₹6,769.30 million |
-8.7% |
| Net Profit: |
₹1,930.96 million |
₹2,136.94 million |
-9.6% |
| Profit Before Tax: |
₹2,582.21 million |
₹2,854.70 million |
-9.5% |
| Basic EPS: |
₹18.17 |
₹20.11 |
-9.6% |
The nine-month results showed a more moderate decline, with revenue decreasing 8.7% and net profit falling 9.6% compared to the same period in the previous fiscal year.
Board Meeting Outcomes and Dividend Declaration
The board of directors, in their meeting held on January 31, 2026, approved the unaudited standalone and consolidated financial results and declared an interim dividend of ₹2.00 per equity share (200%) for the financial year 2025-26:
| Dividend Details: |
Information |
| Interim Dividend: |
₹2.00 per share (200%) |
| Record Date: |
February 6, 2026 |
| Payment Date: |
February 23, 2026 |
| Board Meeting Date: |
January 31, 2026 |
The dividend will be paid to shareholders whose names appear in the company's register of members as on February 6, 2026, which has been fixed as the record date. During the nine-month period, the company allotted 9,240 equity shares of ₹1 each upon exercise of vested stock options under the Employee Stock Option Scheme 2021 (ESOP 2021).
Investor Presentation and Regulatory Compliance
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has submitted its investor presentation for Q3FY26 financial results to both BSE Limited and National Stock Exchange of India Limited. The presentation provides comprehensive insights into the company's quarterly performance and strategic outlook:
| Regulatory Filing Details: |
Information |
| BSE Scrip Code: |
543318 |
| NSE Trading Symbol: |
CLEAN |
| Presentation Date: |
January 31, 2026 |
| Regulatory Compliance: |
SEBI Regulation 30 |
The investor presentation has been made available on the company's official website for stakeholders and investors to access detailed financial information and management commentary.
Earnings Call Recording Submission
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has uploaded the audio recording of the Q3 FY26 Earnings Call held on January 31, 2026, on its official website. The recording provides detailed insights into the company's quarterly performance and management commentary on business operations:
| Earnings Call Details: |
Information |
| Call Date: |
January 31, 2026 |
| Recording Format: |
Audio |
| Regulatory Compliance: |
SEBI Regulation 30 |
| Availability: |
Company website |
The earnings call recording has been made available to stakeholders and investors for comprehensive understanding of the company's financial performance and strategic outlook.